The FDA has given Masimo clearance for its new technology for continuous monitoring of the respiration rate in post operative patients. Masimo’s Rainbow SET Acoustic Monitoring device is worn on the neck where it listens to the upper airway for sounds of breathing.
Masimo Rainbow SET Acoustic Monitoring features an innovative adhesive sensor with an integrated acoustic transducer that is easily and comfortably applied to the patient’s neck to detect upper airway acoustic vibrations on the surface of the skin during the respiratory cycle. Using patented acoustic signal processing that leverages Masimo’s revolutionary Signal Extraction Technology (SET), the respiratory signal is separated and processed to display continuous respiration rate.
When Masimo Rainbow SET Acoustic Monitoring is used in conjunction with Masimo Rainbow SET Pulse CO-Oximetry and the Masimo Patient SafetyNet™ Remote Monitoring and Clinician Notification System, clinicians can follow key indicators of oxygenation with Masimo gold standard SpO2, ventilation with the breakthrough RRa, circulation with Masimo measure through motion pulse rate (PR), and bleeding with Masimo noninvasive and continuous hemoglobin (SpHb™) – enabling them to monitor more patients, more safely, than ever before.
Press release: Masimo Receives FDA Clearance for Masimo Rainbow SET® Acoustic Respiration Rate Monitoring